about
Metabolic alterations and hepatitis C: From bench to bedsideDomain 3 of Hepatitis C Virus Core Protein Is Sufficient for Intracellular Lipid AccumulationHepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic MiceDistinct Roles for Intracellular and Extracellular Lipids in Hepatitis C Virus Infection.Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses.Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis BIncreased α-Fetoprotein Predicts Steatosis among Patients with Chronic Hepatitis C Genotype 4.Hepatitis C virus (HCV) infection and hepatic steatosisHepatitis C Virus-Induced Degradation of Cell Death-Inducing DFFA-Like Effector B Leads to Hepatic Lipid Dysregulation.Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?Associations between responses to interferon therapy and genetic variation in interleukin-28B and the core region of hepatitis C virus genotype 3a.The impact of host metabolic factors on treatment outcome in chronic hepatitis C.Mitochondrial abnormalities in patients with HIV-HCV co-infection as compared to patients with HCV mono-infection.Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis.Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis.Morphometric analysis of hepatic steatosis in chronic hepatitis C infection.Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection.Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin.Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
P2860
Q26773261-F2EB340B-BE20-4781-81B1-4C62747AF11FQ27490435-B37FA129-349F-4C6E-AFCB-6F0563F95AC2Q27490446-A5D4ED2B-2A5C-4859-8BA2-D77DC2E0FEB8Q30276614-2D26319A-944E-49CA-BA1B-DAD59E66534FQ30416248-169111FC-2560-4F59-9AA1-C640A21E3C66Q33582787-C08AF944-9A80-4C26-BB82-3D8C33C5A794Q34394471-C9B7B8EB-E539-466A-AA74-E38496E7789FQ35531310-DDD5DD41-B4E1-41D7-A16E-81F922DCAF69Q35555702-A2DD5BE7-76E1-4E54-A500-867AFDF7AC02Q35999575-9EC4392A-CA40-40B5-B2C1-95851A86CDA0Q36449231-2C8611E5-9560-4DF7-BFAC-FE8466E51741Q36736396-F155B4C4-BE3D-45B6-9C3B-5C61EB02129AQ39036315-53E16815-7B69-479E-8D5E-E49B90696E6DQ41291382-AA7739DE-7D80-4DEA-BF05-A48A7FE122D3Q42152130-61F7AE15-7544-4944-9816-23E12BE5EBE3Q43035090-6A17B9EF-AEA1-4658-951A-799DDB9A83C3Q43039469-23CABC2B-181E-48CD-881A-9F1ABB7EC174Q43040863-A7F3FD17-C6B6-4F86-AC00-73288F30DD82Q43104807-EB92ADAA-9455-4C4A-A676-469D3AB89B4BQ44607576-F31DAC66-29DC-4EC3-B39C-DB924F432FADQ46789982-DC69DF26-4690-47BF-82A3-B08898ACF0ADQ56920945-DC84BBC5-9C1C-4F7C-A444-3F9C4A477839
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hepatitis C virus-induced hepatocellular steatosis.
@ast
Hepatitis C virus-induced hepatocellular steatosis.
@en
type
label
Hepatitis C virus-induced hepatocellular steatosis.
@ast
Hepatitis C virus-induced hepatocellular steatosis.
@en
prefLabel
Hepatitis C virus-induced hepatocellular steatosis.
@ast
Hepatitis C virus-induced hepatocellular steatosis.
@en
P2093
P2860
P1476
Hepatitis C virus-induced hepatocellular steatosis
@en
P2093
Christophe Hezode
Daniel Dhumeaux
Elie-Serge Zafrani
Philippe Chouteau
P2860
P304
P356
10.1111/J.1572-0241.2005.40898.X
P407
P577
2005-03-01T00:00:00Z